Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
53.87
-0.03 (-0.06%)
At close: Aug 6, 2025, 4:00 PM
52.50
-1.37 (-2.53%)
After-hours: Aug 6, 2025, 5:06 PM EDT
BM Technologies Stock Forecast
Stock Price Forecast
The 8 analysts that cover BM Technologies stock have a consensus rating of "Strong Buy" and an average price target of $69.13, which forecasts a 28.34% increase in the stock price over the next year. The lowest target is $57 and the highest is $80.
Price Target: $69.13 (+28.34%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 17, 2025.
Analyst Ratings
The average analyst rating for BM Technologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +33.67% | Jun 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +48.52% | Jun 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +48.52% | May 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +48.52% | Apr 10, 2025 |
| Wedbush | Wedbush | Buy Reiterates $70 | Buy | Reiterates | $70 | +29.95% | Mar 28, 2025 |
Financial Forecast
Revenue This Year
82.91M
from 434.43M
Decreased by -80.91%
Revenue Next Year
126.93M
from 82.91M
Increased by 53.09%
EPS This Year
-1.98
from 4.23
EPS Next Year
-1.79
from -1.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 266.1M | 302.4M | 711.9M | ||
| Avg | 82.9M | 126.9M | 210.4M | ||
| Low | 27.7M | 19.6M | 46.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -38.8% | 264.7% | 460.9% | ||
| Avg | -80.9% | 53.1% | 65.8% | ||
| Low | -93.6% | -76.4% | -63.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.23 | -0.58 | -0.17 | ||
| Avg | -1.98 | -1.79 | -1.23 | ||
| Low | -2.47 | -3.64 | -2.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.